Key result
GYY4137 and Na2S-induced relaxations in rat small mesenteric arteries are inhibited by L-cysteine and KV7 channel blockers.
Why the study?
H2S donors may be beneficial in cardiovascular diseases with decreased plasma H2S levels, prompting investigation of the mechanisms involved in small artery relaxation induced by the slow-releasing H2S donor GYY4137.
p-value: p=<0.05
GYY4137 induces vasorelaxation in rat small mesenteric arteries via potassium channel activation, an effect that is inhibited by L-cysteine, highlighting the importance of H2S release rates.
Should not change practice; leaves open whether KV7-mediated H2S effects translate to human resistance vessels.
Donors of H2S may be beneficial in treating cardiovascular diseases where the plasma levels of H2S are decreased. Therefore, we investigated the mechanisms involved in relaxation of small arteries induced by GYY4137 [(4-methoxyphenyl)-morpholin-4-yl-sulfanylidene-sulfido-λ5-phosphane;morpholin-4-ium], which is considered a slow-releasing H2S donor. Sulfides were measured by use of 5,5′-dithiobis-(2-nitro benzoic acid), and small rat mesenteric arteries with internal diameters of 200–250 µm were mounted in microvascular myographs for isometric tension recordings. GYY4137 produced similar low levels of sulfides in the absence and the presence of arteries. In U46619-contracted small mesenteric arteries, GYY4137 (10−6–10–3 M) induced concentration-dependent relaxations, while a synthetic, sulfur-free, GYY4137 did not change the vascular tone. L-cysteine (10−6–10–3 M) induced only small relaxations reaching 24 ± 6% at 10–3 M. Premixing L-cysteine (10–3 M) with Na2S and GYY4137 decreased Na2S relaxation and abolished GYY4137 relaxation, an effect prevented by an nitric oxide (NO) synthase inhibitor, L-NAME (Nω-nitro-L-arginine methyl ester). In arteries without endothelium or in the presence of L-NAME, relaxation curves for GYY4137 were rightward shifted. High extracellular K+ concentrations decreased Na2S and abolished GYY4137 relaxation suggesting potassium channel-independent mechanisms are also involved Na2S relaxation while potassium channel activation is pivotal for GYY4137 relaxation in small arteries. Blockers of large-conductance calcium-activated (BKCa) and voltage-gated type 7 (KV7) potassium channels also inhibited GYY4137 relaxations. The present findings suggest that L-cysteine by reaction with Na2S and GYY4137 and formation of sulfides, inhibits relaxations by these compounds. The low rate of release of H2S species from GYY4137 is reflected by the different sensitivity of these relaxations towards high K+ concentration and potassium channel blockers compared with Na2S. The perspective is that the rate of release of sulfides plays an important for the effects of H2S salt vs. donors in small arteries, and hence for a beneficial effect of GYY4137 for treatment of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Abramavičius et al. (2021) studied this question. GYY4137 and Sodium Hydrogen Sulfide (Na2S) vs. Control conditions / L-cysteine / K channel blockers was evaluated on Vascular relaxation in U46619-contracted small mesenteric arteries (p=<0.05). GYY4137 and Na2S-induced relaxations in rat small mesenteric arteries are inhibited by L-cysteine and KV7 channel blockers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: